153 related articles for article (PubMed ID: 29700171)
21. Impact of β-globin mutations on outcome of matched related donor hematopoietic stem cell transplantation for patients with β-thalassemia major.
Hamidieh AA; Saber T; Fayyazi S; Jalali A; Behfar M; Hamdi A; Ghavamzadeh A
Biol Blood Marrow Transplant; 2014 Nov; 20(11):1772-6. PubMed ID: 25017762
[TBL] [Abstract][Full Text] [Related]
22. β-Thalassemia major resulting from compound heterozygosity for HBB: c.92+2T>C [formerly known as IVS-I-2 (T>C)] and a novel β(0)-thalassemia frameshift mutation: HBB: c.209delG; p.Gly70Valfs*20.
Kluge ML; Hoyer JD; Swanson KC; Oliveira JL
Hemoglobin; 2014; 38(4):292-4. PubMed ID: 24986053
[TBL] [Abstract][Full Text] [Related]
23. Gene Therapy for beta-thalassemia.
Malik P; Arumugam PI
Hematology Am Soc Hematol Educ Program; 2005; ():45-50. PubMed ID: 16304358
[TBL] [Abstract][Full Text] [Related]
24. Genetic therapy for beta-thalassemia: from the bench to the bedside.
Arumugam P; Malik P
Hematology Am Soc Hematol Educ Program; 2010; 2010():445-50. PubMed ID: 21239833
[TBL] [Abstract][Full Text] [Related]
25. CRISPR/Cas9-mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia.
Yang Y; Kang X; Hu S; Chen B; Xie Y; Song B; Zhang Q; Wu H; Ou Z; Xian Y; Fan Y; Li X; Lai L; Sun X
J Biol Chem; 2021; 296():100464. PubMed ID: 33639162
[TBL] [Abstract][Full Text] [Related]
26. Engineered U7 snRNA mediates sustained splicing correction in erythroid cells from β-thalassemia/HbE patients.
Preedagasamzin S; Nualkaew T; Pongrujikorn T; Jinawath N; Kole R; Fucharoen S; Jearawiriyapaisarn N; Svasti S
Biochem Biophys Res Commun; 2018 Apr; 499(1):86-92. PubMed ID: 29550480
[TBL] [Abstract][Full Text] [Related]
27. Mutation Spectrum of β-Globin Gene in Patients with β-Thalassemia at Tidar Hospital, Magelang, Central Java, Indonesia.
'Ulya NM; Indrawati VN; Wulansari WT; Lesmana I; Handayani NSN
Hemoglobin; 2023 Nov; 47(4):152-156. PubMed ID: 37605561
[TBL] [Abstract][Full Text] [Related]
28. β-Thalassemia due to intronic LINE-1 insertion in the β-globin gene (HBB): molecular mechanisms underlying reduced transcript levels of the β-globin(L1) allele.
Lanikova L; Kucerova J; Indrak K; Divoka M; Issa JP; Papayannopoulou T; Prchal JT; Divoky V
Hum Mutat; 2013 Oct; 34(10):1361-5. PubMed ID: 23878091
[TBL] [Abstract][Full Text] [Related]
29. A Novel Frameshift Mutation at Codons 138/139 (HBB: c.417_418insT) on the β-Globin Gene Leads to β-Thalassemia.
Jiang F; Huang LY; Chen GL; Zhou JY; Xie XM; Li DZ
Hemoglobin; 2017 Jan; 41(1):59-60. PubMed ID: 28460555
[TBL] [Abstract][Full Text] [Related]
30. Hemoglobin gene therapy for β-thalassemia.
Bank A
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
[TBL] [Abstract][Full Text] [Related]
31. A Patient with β-Thalassemia Intermedia Secondary to Homozygosity for a Polyadenylation Signal Mutation (AATAAA > AATAGA) (HBB: C.*112A > G) on the β-Globin Gene.
Lim YC; Tan KM; Chong SS; Rajendran J; Sampath V
Hemoglobin; 2016 Sep; 40(5):359-360. PubMed ID: 27821013
[TBL] [Abstract][Full Text] [Related]
32. Two novel mutations in the 3' untranslated region of the beta-globin gene that are associated with the mild phenotype of beta thalassemia.
Bilgen T; Clark OA; Ozturk Z; Akif Yesilipek M; Keser I
Int J Lab Hematol; 2013 Feb; 35(1):26-30. PubMed ID: 22862814
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Nonsense Mediated Decay on Transcriptional Activity Within the Novel β-Thalassemia Mutation HBB: c.129delT.
Forster L; Ardakani RM; Qadah T; Finlayson J; Ghassemifar R
Hemoglobin; 2015; 39(5):334-9. PubMed ID: 26207313
[TBL] [Abstract][Full Text] [Related]
34. Enhancement of β-Globin Gene Expression in Thalassemic IVS2-654 Induced Pluripotent Stem Cell-Derived Erythroid Cells by Modified U7 snRNA.
Phanthong P; Borwornpinyo S; Kitiyanant N; Jearawiriyapaisarn N; Nuntakarn L; Saetan J; Nualkaew T; Sa-Ngiamsuntorn K; Anurathapan U; Dinnyes A; Kitiyanant Y; Hongeng S
Stem Cells Transl Med; 2017 Apr; 6(4):1059-1069. PubMed ID: 28213976
[TBL] [Abstract][Full Text] [Related]
35. Control of human beta-globin mRNA stability and its impact on beta-thalassemia phenotype.
Peixeiro I; Silva AL; Romão L
Haematologica; 2011 Jun; 96(6):905-13. PubMed ID: 21357703
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic Effects of Hematopoietic Stem Cell Derived From Gene-Edited Mice on β654-Thalassemia.
Lu D; Gong X; Guo X; Chen Y; Zhu Y; Fang Y; Cai Q; Xu M; Yang H; Li D; Zeng Y; Zeng F
Stem Cells; 2024 Mar; 42(3):278-289. PubMed ID: 38134938
[TBL] [Abstract][Full Text] [Related]
37. A novel frameshift mutation at codon 66 (HBB:c.del201A) in the β-globin gene leads to beta-thalassemia.
Yu N; Kim HR; Cha YJ; Park EK
Ann Hematol; 2011 Feb; 90(2):243-4. PubMed ID: 20532507
[No Abstract] [Full Text] [Related]
38. Correction of β654-thalassaemia mice using direct intravenous injection of siRNA and antisense RNA vectors.
Xie SY; Li W; Ren ZR; Huang SZ; Zeng F; Zeng YT
Int J Hematol; 2011 Mar; 93(3):301-310. PubMed ID: 21369857
[TBL] [Abstract][Full Text] [Related]
39. Recent Progress on Genetic Diagnosis and Therapy for β-Thalassemia in China and Around the World.
Zhang J; Yan J; Zeng F
Hum Gene Ther; 2018 Feb; 29(2):197-203. PubMed ID: 29357712
[TBL] [Abstract][Full Text] [Related]
40. A novel homozygous point mutation at codon 82 (HBB:c.247A > T) in the beta-globin gene leads to thalassemia major.
Angalena R; Prabitha KN; Chaudhary AK; Bashyam MD; Jain S; Dalal AB
Int J Lab Hematol; 2010 Oct; 32(5):548-9. PubMed ID: 20136848
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
